Comparison of intensive insulin therapy and conventional glucose management in patients undergoing coronary artery bypass grafting

被引:3
|
作者
Mohod, Vaishali [1 ]
Ganeriwal, Veena [1 ]
Bhange, Juilee [1 ]
机构
[1] Grant Med Coll & Sir JJ Grp Hosp, Dept Anaesthesiol & Crit Care, Mumbai, Maharashtra, India
关键词
Coronary artery bypass grafting; glycemic control; intensive insulin therapy; CARDIAC-SURGERY; NONDIABETIC PATIENTS; GLYCEMIC CONTROL; DIABETICS; MORTALITY;
D O I
10.4103/joacp.JOACP_61_17
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and Aims: Hyperglycemia during cardiac surgery is a risk factor for postoperative outcomes. Because incidence of diabetes mellitus is increasing in Indian population, we tried to evaluate the western protocol for strict control of blood sugar perioperatively. The main aim of the study was to evaluate glycemic control during coronary artery bypass grafting and to determine whether intensive insulin therapy (IIT) is better than the conventional one. Material and Methods: A prospective randomized comparative study was conducted to evaluate IIT and conventional management of glucose in 40 patients undergoing on-pump coronary artery bypass grafting. Outcomes measured were incidence of hyperglycemia or hypoglycemia, incidence of hypokalemia, prolonged intubation, wound infections, strokes, acute renal failure, new onset arrhythmias, length of stay in ICU and hospital, cardiac arrest and mortality. The statistical analysis was done by using Chi-square test, and paired and unpaired t test. Results: The diabetic patients had significantly higher mean blood sugar and insulin requirement. The incidence of hyperglycemia was significantly higher in conventional management of blood sugar (P = 0.001), whereas hypoglycemia (P = 0.047) and hypokalemia (P = 0.020) were significantly higher in IIT. There were no significant difference in the incidence of prolonged intubation, wound infection, length of ICU and hospital stay, strokes, acute renal failure, new onset arrhythmias, cardiac arrest, and mortality. Conclusion: The IIT did not improve the morbidity and mortality in our patients undergoing coronary artery bypass grafting.
引用
收藏
页码:493 / 497
页数:5
相关论文
共 50 条
  • [21] Management of Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Grafting Review of the Literature
    Khiabani, Ali J.
    Adademir, Taylan
    Schuessler, Richard B.
    Melby, Spencer J.
    Moon, Marc R.
    Damiano, Ralph J., Jr.
    INNOVATIONS-TECHNOLOGY AND TECHNIQUES IN CARDIOTHORACIC AND VASCULAR SURGERY, 2018, 13 (06) : 383 - 390
  • [22] Management of patients with asymptomatic moderate aortic stenosis undergoing coronary artery bypass grafting
    Touati, GD
    Carmi, D
    Trojette, F
    Bidaud, M
    Popesco, D
    Ben Amar, A
    Poulain, H
    JOURNAL OF HEART VALVE DISEASE, 2002, 11 (02): : 210 - 216
  • [23] High dose insulin therapy attenuates systemic inflammatory response in patients undergoing elective coronary artery bypass grafting
    AlBacker, Turki B.
    Carvalho, George
    Schricker, Thomas
    Lachapelle, Kevin
    CIRCULATION, 2006, 114 (18) : 659 - 659
  • [24] Transfusion practices in patients undergoing coronary artery bypass grafting
    Sehgal, LR
    Shah, NA
    Zebala, LP
    Curran, RD
    Alexander, JC
    Votapka, TV
    Caprini, JA
    THROMBOSIS AND HAEMOSTASIS, 1999, : 364 - 365
  • [25] Quality of Life of patients undergoing coronary artery bypass grafting
    Matos Dal Boni, Andreia Lima
    Martinez, Jose Eduardo
    Ribeiro da Silva Saccomann, Izabel Cristina
    ACTA PAULISTA DE ENFERMAGEM, 2013, 26 (06) : 575 - 580
  • [26] Comparison of hydroxyl radical generation in patients undergoing coronary artery bypass grafting with and without cardiopulmonary bypass
    Osaka, M
    Aoyagi, K
    Hirakawa, A
    Nakajima, M
    Jikuya, T
    Shigeta, O
    Sakakibara, Y
    FREE RADICAL RESEARCH, 2006, 40 (02) : 127 - 133
  • [27] Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting
    Furnary, AP
    Gao, GQ
    Grunkemeier, GL
    Wu, YX
    Zerr, KJ
    Bookin, SO
    Floten, HS
    Starr, A
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 125 (05): : 1007 - 1021
  • [28] The pharmacokinetics of remifentanil in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass
    Michelsen, LG
    Holford, NHG
    Lu, W
    Hoke, JF
    Hug, CC
    Bailey, JM
    ANESTHESIA AND ANALGESIA, 2001, 93 (05): : 1100 - 1105
  • [29] Discontinuation of dual antiplatelet therapy and bleeding in intensive care in patients undergoing urgent coronary artery bypass grafting: a retrospective analysis
    Vuilliomenet, Thierry
    Gebhard, Caroline
    Bizzozero, Chiara
    Glauser, Salome
    Blum, Steffen
    Buser, Andreas
    Bolliger, Daniel
    Grapow, Martin T. R.
    Siegemund, Martin
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2019, 28 (05) : 665 - 673
  • [30] Evaluation of Conventional and Novel Risk Factors in Young and Aged Patients, Undergoing Coronary Artery Bypass Grafting
    Chakrabarty, Ushnish
    Yadav, Surendra S.
    Datta, Swarnendu
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2024, 16 : S2215 - S2217